Cannabinoids: current and future options to treat chronic and chemotherapy-induced neuropathic pain

HL Blanton, J Brelsfoard, N DeTurk, K Pruitt… - Drugs, 2019 - Springer
Increases in cancer diagnosis have tremendous negative impacts on patients and their
families, and major societal and economic costs. The beneficial effect of chemotherapeutic …

[PDF][PDF] An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part I: introduction and general considerations

L Manchikanti, F Falco, V Singh… - Pain …, 2013 - painphysicianjournal.com
In 2000, the American Society of Interventional Pain Physicians (ASIPP) created treatment
guidelines to help practitioners. There have been 5 subsequent updates. These guidelines …

[HTML][HTML] Effects of delta-9-tetrahydrocannabinol and cannabidiol on cisplatin-induced neuropathy in mice

HM Harris, KJ Sufka, W Gul, MA ElSohly - Planta medica, 2016 - thieme-connect.com
Sativex, a cannabinoid extract with a 1: 1 ratio of tetrahydocannabinol and cannabidiol, has
been shown to alleviate neuropathic pain associated with chemotherapy. This research …

Validating antibodies to the cannabinoid CB2 receptor: antibody sensitivity is not evidence of antibody specificity

Y Marchalant, PW Brownjohn… - … of Histochemistry & …, 2014 - journals.sagepub.com
Antibody-based methods for the detection and quantification of membrane integral proteins,
in particular, the G protein-coupled receptors (GPCRs), have been plagued with issues of …

Dynamic changes to the endocannabinoid system in models of chronic pain

D Rani Sagar, JJ Burston… - … of the Royal …, 2012 - royalsocietypublishing.org
The analgesic effects of cannabinoid ligands, mediated by CB1 receptors are well
established. However, the side-effect profile of CB1 receptor ligands has necessitated the …

The CB2 cannabinoid receptor as a therapeutic target in the central nervous system

D Cabañero, E Martín-García… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Targeting CB2 cannabinoid receptor (CB2r) represents a promising approach
for the treatment of central nervous system disorders. These receptors were identified in …

[HTML][HTML] Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats

J Niu, D Huang, R Zhou, MX Yue, T Xu, J Yang… - Journal of …, 2017 - Springer
Background More evidence suggests that dorsal spinal cord microglia is an important site
contributing to CB2 receptor-mediated analgesia. The upregulation of P2Y 12 and P2Y 13 …

The development of cannabinoids as therapeutic agents in the United States

CH Murray, BM Gannon, PJ Winsauer, ZD Cooper… - Pharmacological …, 2024 - ASPET
Cannabis is one of the oldest and widely used substances in the world. Cannabinoids within
the cannabis plant, known as phytocannabinoids, mediate cannabis9 effects through …

[HTML][HTML] Cannabis and endometriosis: The roles of the gut microbiota and the endocannabinoid system

T Farooqi, DJ Bhuyan, M Low, J Sinclair… - Journal of Clinical …, 2023 - mdpi.com
Endometriosis, a chronic condition affecting around 10–14% of women, is challenging to
manage, due to its complex pathogenesis and limited treatment options. Research has …

[HTML][HTML] Crotalphine modulates microglia M1/M2 phenotypes and induces spinal analgesia mediated by opioid-cannabinoid systems

FSR Lopes, AC Giardini, MB Sant'Anna… - International Journal of …, 2022 - mdpi.com
Pain is a worldwide public health problem and its treatment is still a challenge since
clinically available drugs do not completely reverse chronic painful states or induce …